LINC01818

Across TCGA pan-cancer cohorts, LINC01818 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC01818 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC01818 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01818 expression acts as an unfavorable survival marker, although some lineages such as LIHC and UCS show a favorable association.

HNSC, READ, and LIHC are the cancer types where LINC01818 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	III,IV	0.311	0.667	.004	72	view →
READ	DFS	Tertile	All	0.083	0.825	<.001	72	view →
LIHC	OS	Tertile	All	0.880	0.732	.003	60	view →
COAD	OS	Tertile	III,IV	0.275	0.698	.011	54	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
CHOL	OS	Tertile	II,III,IV	0.019	0.675	<.001	36	view →
GBM	OS	Tertile	All	0.066	0.422	<.001	27	view →
LGG	DFS	Tertile	All	0.230	0.753	.005	27	view →
OV	OS	Tertile	II,III,IV	0.695	0.847	.019	18	view →
SKCM	OS	Tertile	II,III,IV	0.339	0.742	.014	18	view →
UCS	DFS	Tertile	II,III,IV	0.851	0.361	.018	12	view →
UCEC	DFS	Tertile	All	0.423	0.659	.012	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LINC01818–HNSC (OS)

Open the HNSC breakdown →